歐普康視(300595.SZ):擬對六安康視增資1150.10萬元佔股51%
格隆匯12月3日丨歐普康視(300595.SZ)公佈,2019年12月3日,公司與鍾文秀、陳寶海在安徽省合肥市簽訂了《歐普康視科技股份有限公司與鍾文秀、陳寶海關於六安康視醫療科技有限公司之投資合作協議》。公司擬以募集資金1150.10萬元以增資擴股的方式投資於六安康視醫療科技有限公司(“六安康視”),此次投資完成後,公司將持有六安康視51%的股權。
六安康視及其下轄的兩家子公司“六安視立佳醫療科技有限公司(“視立佳”)”、“六安瑞視眼科醫院有限公司(“瑞視”)”位於安徽省六安市。六安康視以視光配鏡、眼視光產品銷售和技術服務為主營業務,經營團隊業務能力較強,具有本地資源優勢。該公司自開業以來業務穩步發展、盈利狀況表現良好。“視立佳”系六安康視的全資子公司,以眼視光產品銷售為主營業務,業務增長潛力較大。“瑞視”為六安康視的控股子公司,是一家以眼視光服務和眼科醫療為主的醫院,目前處於建設階段,鑑於核心團隊在經驗、業務、資源等方面的優勢,“瑞視”具有良好的發展前景。
2019年1-10月六安康視營業收入為286.71萬元,淨利潤為119.29萬元(不含控股子公司六安瑞視眼科醫院有限公司)。2019年10月末六安康視資產總額為834.48萬元,負債總額為423.19萬元,淨資產為411.29萬元(不含控股子公司六安瑞視眼科醫院有限公司)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.